Skip to content

Salvia divinorum: An overview of the usage, misuse, and addiction processes.

Rathi Mahendran, Haikel A Lim, Joyce Y S Tan, Shi Min Chua, Munidasa Winslow

Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists March 1, 2016 DOI: 10.1111/appy.12225 via PubMed

Summary

AI-generated from the abstract

Salvia divinorum, a plant used for centuries in South American religious rituals, has become popular among adolescents and young adults as a readily available 'legal high' purchased online. Its main active compound, Salvinorin A, is a potent κ-opioid agonist. Although the short- and long-term effects are not well-studied, it is widely believed to have low addictive potential and low toxicity. However, recent findings suggest that Salvinorin A can precipitate psychiatric symptoms and negatively affect cognition. Its increasing use requires clinicians to be aware of its effects.

Study at a glance

Characteristics Review Peer reviewed
Topics Salvia divinorum
Keywords Novel psychoactive substance
Key finding Salvinorin A can precipitate psychiatric symptoms and negatively affect cognition.

Abstract

Salvia divinorum, a sage plant with leaves that can produce a psychoactive high, has been used for hundreds of years for its psycho-mimetic effects in religious rituals in South America. Salvia has now become popular mainly with adolescents and young adults for the short-lived relatively pleasant experiences many consider a "legal high" and its ready availability through Internet purchases. The main (psycho)active compound in salvia is Salvinorin A, a potent κ-opioid agonist and although the short and long-term effects have not been examined in sufficient detail, it is widely believed to have low addictive potential and low toxicity. Recent findings, however, seem to suggest that Salvinorin A can precipitate psychiatric symptoms and negatively affect cognition. Its ready availability and increasingly widespread use requires clinicians to have knowledge and awareness of its effects.

Explore topics

Comments

No comments yet.

Log in to comment